- Apr 30, 2020
- Business Update
JD’s Nucleic Acid Test Booking for Groups Covers 31 Cities
by Tracy Yang
On April 28th, JD Health announced a partnership with leading testing institutions in the industry, including KingMed, USCI, CapitalBio eHealth, BGI, ADICON, Biomedlab and Xiaoniaokuaiyan to launch group nucleic acid testing appointment services, so as to ensure the smooth development of the resumption of work, production and school in China. Just last week, JD and KingMed opened China’s first COVID-19 nucleic testing online reservation platform and expanded it to 11 cities across the country.
Currently the nucleic acid testing group service provided by JD Health covers 31 cities, including Beijing, Shanghai, Shenzhen, Tianjin and Hangzhou, and the number of service sites has reached 96. Online reservation services in more cities are on the way. It is worth mentioning that Wuhan, Xiaogan and Yichang, three cities in Hubei province, are covered by the testing services.
Enterprises, schools, and relevant institutions with COVID-19 testing needs may open JD.com ‘s App, search for “Nucleic Acid Testing” (in Chinese) to enter the reservation page, and follow the procedure to make group orders and organize personnel to go to the selected testing sites for sampling at the scheduled time. Within 24 hours, they can check the test report online. If the group has more than 50 people and has the proper sampling environment, they can do the testing at their locations instead of a testing site.
In addition, JD.com is also opening more entrances to help enterprise customers make reservations. In addition to the reservation methods above, enterprise customers can also log on to JD Business (https://b.jd.com), JD.com’s enterprise procurement portal, or go to the “Enterprise Procurement” channel on the JD app.